Market Signal Briefing

Adoption Bitcoin Bitcoin Price Prediction Market

Ad Disclosure

Ad Disclosure

We believe in full transparency with our readers. Some of our content includes affiliate links, and we may earn a commission through these partnerships. However, this potential compensation never influences our analysis, opinions, or reviews. Our editorial content is created independently of our marketing partnerships, and our ratings are based solely on our established evaluation criteria. Read More

Ad Disclosure

Ad Disclosure

We believe in full transparency with our readers. Some of our content includes affiliate links, and we may earn a commission through these partnerships. However, this potential compensation never influences our analysis, opinions, or reviews. Our editorial content is created independently of our marketing partnerships, and our ratings are based solely on our established evaluation criteria. Read More

Ahmed Balaha

Author

Ahmed Balaha

Part of the Team Since

Aug 2025

About Author

Ahmed Balaha is a journalist and copywriter based in Georgia with a growing focus on blockchain technology, DeFi, AI, privacy, digital assets, and fintech innovation.

Has Also Written

Ad Disclosure

Ad Disclosure

We believe in full transparency with our readers. Some of our content includes affiliate links, and we may earn a commission through these partnerships. However, this potential compensation never influences our analysis, opinions, or reviews. Our editorial content is created independently of our marketing partnerships, and our ratings are based solely on our established evaluation criteria. Read More

Last updated: 

February 18, 2026

Abu Dhabi just made a quiet but massive Bitcoin bet.

Sovereign linked investors disclosed more than $1.04B in U.S. spot Bitcoin ETFs at the end of 2025. Mubadala Investment Company alone reported over 12.7M shares of BlackRock spot Bitcoin ETF, worth about $630.7M.

Source: SECAl Warda Investments added another 8.2M shares, valued near $408.1M. Combined, that is roughly 20.9M shares tied to one of the largest Bitcoin ETF issuers in the world.

This is not retail speculation. It is state backed capital allocating at scale.

The filings come as Bitcoin ETFs recorded $104.87M in daily net outflows and short term selling pressure returned. Spot Bitcoin has been hovering near the mid $60,000 range while broader sentiment remains fragile.

Source: CoinglassYet these positions reflect holdings as of Dec. 31. That suggests a longer term allocation strategy rather than tactical trading.

Bitcoin Price Prediction: Are Governments Keeping Price At This Level To Accumulate?Bitcoin is still compressing between clear levels.

On the chart, price bounced hard from the $60K–$64K demand zone and is now ranging just under the $70K–$71K resistance band.

That area keeps capping upside. A clean break and hold above $71K would shift short term structure and open the path toward $80K, then $90K.

Source: BTCUSD / TradingViewThe downside is simple. $64K is the key floor. Lose it, and $60K comes back into play fast.

Now, zoom out and connect it slightly to the ETF story. While price is chopping and sentiment feels fragile, sovereign-sized allocations are quietly building in the background.

If structure keeps improving and $71K eventually flips into support, price could start catching up to that longer-term positioning. For now, it is a battle between range resistance and a base trying to form above $64K.

While Governments Accumulate, Bitcoin Hyper Could Activate CapitalState-backed money can afford patience. They allocate. They wait. They hold through volatility.

Retail does not always move that way.

Bitcoin Hyper ($HYPER) is built for participants who want more than slow range compression. This Bitcoin-focused Layer-2, powered by Solana technology, adds speed, lower fees, and real on-chain utility while preserving Bitcoin’s core security.

It keeps the brand strength of Bitcoin but unlocks actual activity on top of it. Payments. Staking. Scalable execution.

Momentum is already visible. The Bitcoin Hyper presale has raised over $31 million so far, with $HYPER priced at $0.0136751 before the next increase. Staking rewards currently reach up to 37%.

If Bitcoin eventually breaks $71K, great. If it keeps chopping while institutions accumulate, Bitcoin Hyper could be positioned to move regardless.

Visit the Official Bitcoin Hyper Website Here

Governance Tensions Rise at BNB Treasury Firm as Major Holders Clash Over SEC Disclosures Prefer us on Google

YZi Labs accuses 10X Capital of not disclosing a more than 5% BNC stake.BNC board seeks to amend asset deal with 10X amid rising tensions.Dispute raises governance concerns at a major BNB treasury firm.Binance-affiliated investment firm YZi Labs (formerly Binance Labs) publicly accused asset manager 10X Capital on Wednesday of failing to comply with US securities disclosure requirements. The dispute comes amid broader governance changes at CEA Industries.

In an official blog post, the firm alleged that 10X Capital failed to comply with SEC rules requiring disclosure of ownership stakes once a certain threshold is reached.

Sponsored

YZi Labs Accuses 10X Capital of Reporting ViolationsThe dispute centers on CEA Industries, known by its Nasdaq ticker, BNC. The company describes itself as managing the world’s largest corporate treasury of BNB. 

For crypto market participants, the situation is particularly relevant. BNC’s treasury strategy ties it closely to the Binance ecosystem. Governance or asset management changes at the company could affect how its large BNB holdings are managed.

Both YZi Labs and 10X Capital hold positions in BNC, and recent developments indicated an escalating contest over governance. 

The latest accusations come just one week after BNC publicly refuted earlier claims made by YZi Labs regarding the company’s compliance with Nasdaq rules tied to the timing of its Annual Meeting of Stockholders. In that February 13 statement, BNC said it was fully compliant and rejected what it described as “false” and “reckless” assertions.

In a formal letter addressed to 10X Capital on Wednesday, YZi Labs alleged that the asset manager failed to properly report its ownership stake in CEA Industries.

Sponsored

Under US securities law, investors who accumulate more than 5% of a public company’s shares must disclose their holdings. That way, other shareholders are aware of potential shifts in influence.

According to YZi Labs, 10X Capital has owned more than 5% of BNC’s shares since late 2025. However, it did not file a Schedule 13D to formally report that stake or disclose that it may have been acting together with other shareholders.

YZi Labs also alleged that 10X Capital founder Hans Thomas, who serves on BNC’s board, did not submit the required SEC filing that directors must complete to disclose their initial share ownership in the company.

“SEC disclosure rules are not ‘personal preferences’ or ‘optional housekeeping’ – they are the baseline standard and non-negotiable obligations for anyone who wants a seat on a public company Board,” said Alex Odagiu, an investment partner at YZi Labs. “If you cannot manage timely Section 16 filings and clear ownership disclosure, you should not be managing a public company.”

Sponsored

The allegations surfaced the same day BNC’s Board of Directors announced a proposal to amend its Asset Management Agreement with 10X Capital. 

Governance Stakes Rise Over Asset DealIn its proposal, the Board said it is seeking lower management fees, a shorter contract term, and more flexible termination provisions. It described the move as part of a broader effort to enhance operational flexibility and long-term value.

It followed what it described as a comprehensive review of the agreement and came after YZi Labs publicly confirmed the termination of a previously undisclosed side agreement with 10X that had restricted amendments to the deal. 

🔔 $BNC Board is moving forward with a proposal to amend the Asset Management Agreement with 10X Capital.

Seeking:
• Lower fees
• Shorter term
• Better termination rights

10X has indicated willingness to renegotiate.

Look forward to constructive discussions ahead for the…

— BNB Network Company (BNC) (@BNBNetworkCo) February 18, 2026 Sponsored

With that restriction lifted, the Board said it is moving forward with renegotiation discussions.

The developments unfold alongside YZi Labs’ own regulatory filings. The investment firm previously disclosed that it had crossed the 5% ownership threshold following the company’s share repurchases and later formed a shareholder group.

Crossing that threshold is significant under both federal securities law and Nevada corporate law, where CEA Industries is incorporated. 

While federal rules require disclosure, Nevada law governs shareholder rights and board authority. Ownership levels can affect a shareholder’s ability to initiate actions, such as consent solicitations, or to influence governance decisions.

Against that backdrop, the timing of the disclosure dispute and the Board’s push to revise 10X’s asset management agreement suggest the disagreement may extend beyond regulatory filings. It may also reflect deeper questions over control and strategic direction at the BNB-focused public company.

Disclaimer

In adherence to the Trust Project guidelines, BeInCrypto is committed to unbiased, transparent reporting. This news article aims to provide accurate, timely information. However, readers are advised to verify facts independently and consult with a professional before making any decisions based on this content. Please note that our Terms and Conditions, Privacy Policy, and Disclaimers have been updated.

TLDR:

The cryptocurrency records a 40% growth over the past seven days, outperforming Bitcoin and Ethereum. The launch of key mainnet updates on February 15 acts as the primary catalyst for the surge. CoinCodex analysts project a technical correction toward $0.13 by the end of the month despite current optimism. The digital asset market’s full attention is centered on the recent Pi Coin pump, which is consolidating as one of the top-performing assets. With an increase exceeding 5% in the last 24 hours and nearly 18% over 15 days, the asset stands out in a low-liquidity context.

This bullish rally appears directly linked to progress in its mainnet launch initiated in mid-February. The project presented this phase as a crucial step toward deep decentralization, an achievement that investors have decided to reward with strength.

In addition to technological optimism, the asset took advantage of a brief Bitcoin awakening toward $70,000 to gain initial traction. Although the pioneer crypto failed to sustain its position, PI maintained its momentum thanks to capital rotation from traders seeking higher yields.

Risks of correction and the FOMO factor in the market Despite the strength shown, analysts warn that the sustainability of this rise depends on the behavior of leading assets. If Bitcoin continues to be weak, investors are likely to begin taking profits aggressively, halting the ascent.

On the other hand, the phenomenon known as FOMO (fear of missing out) could keep the price in the green for longer than expected. Being one of the few positive assets, many traders are tempted to enter the position simply due to the market’s momentum.

In summary, although the progress toward the mainnet is a solid catalyst, the macroeconomic environment remains fragile. Market participants should monitor support levels, as a potential 31% drop is estimated if the initial optimism begins to fade.

Trusted Editorial content, reviewed by leading industry experts and seasoned editors. Ad Disclosure

The price of Dogecoin (DOGE) is steadily approaching a critical level that could shape its next significant move. According to a crypto analyst closely tracking the meme coin’s price action, a reaction at this key level could form a “divergence,” a technical pattern often associated with a major trend reversal. 

On Tuesday, February 17, crypto market analyst NaBer shared fresh updates on Dogecoin in an X post, providing his latest insights into the meme coin’s recent price action. Specifically, he highlighted a key horizontal zone around $0.10 on the DOGE chart, noting that this area would be his primary watch zone if he were considering adding more to his position. 

The analyst admitted to already holding some DOGE tokens at around $0.10 and outlined a simple plan based on whether the meme coin can hold or form a divergence. The one-week chart shared in the post shows Dogecoin’s price compressing directly above a long-standing support band that previously acted as resistance during earlier cycles. This support is marked by a green horizontal zone around $0.07 and $0.10. 

Interestingly, NaBer’s focus is not only on horizontal support but also on the structure. The chart shows a sequence of lower highs, with a recent swing high that has fallen well below previous peaks. At the same time, the weekly candles are grinding into support, with a slight descending trendline pressing down from the right and price action tightening into a narrowing wedge against the horizontal support. 

Source: Chart from NaBer on X While Dogecoin’s price has been making new lows around the $0.10 support, the Relative Strength Index (RSI) in the chart is at 34.78, down from a previous reading of 37.22, indicating that momentum is flattening. NaBer has said he wants to see a possible divergence and, ideally, some Lower Time Frame (LTF) volume stepping in, signaling that buyers are absorbing supply at this range. 

The analyst has also made it clear that he intends to closely watch for an ABC structure or an LTF impulse before making any aggressive projections. He agreed that an impulsive move will be enough confirmation of a divergence formation. 

DOGE Bearish Channel Flips Bullish In his latest Dogecoin analysis, crypto expert Trader Tardigrade stated that the DOGE price has officially transitioned from a descending channel downtrend into an ascending channel uptrend. According to him, the meme coin’s price recently broke out of its bearish structure and tested the lower support below $0.083. 

After this, Dogecoin entered a new bullish channel and is now trending upwards within higher lows and higher highs. Trader Tardigrade has characterized this price behavior as a textbook trend reversal. He said Dogecoin has finally shifted momentum, projecting a possible price rally toward $0.165. 

DOGE trading at $0.10 on the 1D chart | Source: DOGEUSDT on Tradingview.com Featured image from Peakpx, chart from Tradingview.com

Editorial Process for bitcoinist is centered on delivering thoroughly researched, accurate, and unbiased content. We uphold strict sourcing standards, and each page undergoes diligent review by our team of top technology experts and seasoned editors. This process ensures the integrity, relevance, and value of our content for our readers.

Sign Up for Our Newsletter! For updates and exclusive offers enter your email.

Scott Matherson is a leading crypto writer at Bitcoinist, who possesses a sharp analytical mind and a deep understanding of the digital currency landscape. Scott has earned a reputation for delivering thought-provoking and well-researched articles that resonate with both newcomers and seasoned crypto enthusiasts. Outside of his writing, Scott is passionate about promoting crypto literacy and often works to educate the public on the potential of blockchain.

TLDR:

BTC price is stabilizing in a high-volume trading zone located between $60,000 and $72,000. A stochastic golden cross has appeared on the weekly chart following weeks of bearish pressure from 2025 highs. If current levels hold, analysts project a potential technical rally that could drive the cryptocurrency toward $87,000. Following the pioneer crypto’s retreat from its all-time highs, the market is undergoing a critical consolidation phase. Currently, Bitcoin liquidity support is being tested in the $67,000 area, a point where CME futures contracts show a high density of historical activity.

This zone appears to be a technical battleground, with buyers and sellers accumulating large positions. Therefore, maintaining the price above this liquidity floor is vital to avoid a search for much lower support levels.

Despite recent negative monthly closes, the market structure is shifting from a trend extension to an equilibrium phase. As a result, investors are closely watching to see if this high-demand zone will serve as a springboard for a new upward movement.

The stochastic indicator and the potential for a 20% rebound On the Binance weekly chart, a stochastic golden cross is flashing while the price trades near $68,000. Generally, this indicator precedes short-term recovery phases, having driven rebounds between 15% and 21% previously during the last semester.

However, the stochastic oscillator is still at low levels, framing this signal as a momentum reset rather than a definitive trend reversal. Consequently, any rally will first have to face the dense supply accumulated in the $70,000 zone.

In summary, the combination of solid support and technical signals of seller exhaustion suggests imminent stabilization. The market now awaits a breakout from current ranges to confirm whether the $87,000 target is once again within reach for the bulls.

Bitcoin continues to trade within a tight range, but beneath the surface, structural weakness is becoming increasingly evident. With price holding below the key $72,000 level, now acting as resistance, the broader technical outlook remains fragile, and any short-term consolidation may simply be masking underlying downside risk.

Bitcoin Enters Clear Corrective Phase Bitcoin has entered a clear corrective phase after peaking in the $120,000–$125,000 region. Crypto analyst Alejandro₿TC notes that the weekly structure has broken to the downside, with the latest leg unfolding impulsively, a sign that momentum currently favors sellers rather than buyers.

The key level to watch is the $72,000–$74,000 zone. Previously acting as strong support, this area has now been lost and flipped into resistance. As long as Bitcoin continues to close below this range on the weekly timeframe, any upward movement should be viewed as a corrective bounce rather than confirmation of a sustained reversal.

Source: Chart from Alejandro₿TC on X On the downside, the $50,000–$52,000 region stands out as the primary magnet. This zone represents a significant weekly demand area and the base of the prior impulsive rally. If bearish pressure persists, it becomes the most logical target for a deeper retracement.

The upcoming monthly close in 11 days could be decisive. A close below $72,000 would confirm the breakdown and increase the probability of further downside. Structurally, the market remains weak beneath that level, while a decisive reclaim above $74,000 would mark the first meaningful signal that strength is returning.

Compression Intensifies Near $68,000 With volatility compressing as price trades within an increasingly narrow band, Bitcoin continues to coil tightly around the $67,000–$68,000 region. The lack of decisive movement in either direction suggests that the market is building energy for a larger expansion move. 

According to Columbus, liquidity continues to build above the $70,000 level, and notable bids remain layered between $64,000 and $66,000. With liquidity stacked on both sides, the market is effectively squeezed between opposing forces, waiting for a catalyst.

The longer Bitcoin remains trapped inside this tightening structure, the more aggressive the eventual breakout tends to be. Compression phases like this typically end with strong displacement, as one side of the market is forced to unwind positions. 

From here, sustained acceptance above the $69,500–$70,000 area would likely open the door for momentum toward heavier liquidity zones overhead. On the other hand, failure to reclaim that threshold keeps downside probes into the mid-$60,000s firmly in play, especially if bids begin to thin out under pressure. The next decisive move will likely be driven by which side of liquidity gets targeted first.

BTC trading at $68,014 on the 1D chart | Source: BTCUSDT on Tradingview.com Featured image from Pixabay, chart from Tradingview.com

Ethereum has reached a symbolic milestone, with more than 50% of all historically issued ether (ETH) now sent to the network’s proof-of-stake (PoS) deposit contract, according to on-chain analytics firm Santiment. The announcement has fueled debate among crypto analysts over what the figure truly represents for Ethereum’s circulating supply and staking activity.

Santiment reported that 50.18% of ETH ever issued has flowed into the Beacon Chain deposit contract since staking was introduced before Ethereum’s 2022 transition from proof-of-work to proof-of-stake. With Ethereum’s total supply currently at approximately 120.69 million ETH, blockchain data shows the deposit contract holding over 80 million ETH. Major holders include Binance, BlackRock, Coinbase, and Bitmine, one of the largest ether-focused treasury firms.

However, analysts caution that the 50% milestone may be misleading. Luke Nolan, senior research associate at CoinShares, noted that the Beacon deposit contract reflects cumulative deposits rather than the amount of ETH actively staked. Since the Shanghai upgrade in 2023 enabled withdrawals, validators can exit and return ETH to circulation. Withdrawals are processed by minting ETH back to execution-layer addresses, meaning the deposit contract balance does not decrease when funds are withdrawn.

Current data from Ethplorer and CryptoQuant indicates that around 37.25 million ETH—roughly 30% of the circulating supply—is actively staked. This distinction significantly alters the narrative around Ethereum’s supply lock and liquidity dynamics.

Despite the controversy, staking growth highlights Ethereum’s evolving economic model. Industry leaders argue that rising validator participation positions ETH as a yield-bearing “digital bond,” reinforcing network security through long-term commitment. At the same time, recent validator growth appears increasingly driven by institutional players and crypto ETFs.

As Ethereum staking continues to expand, how supply metrics are calculated and presented will remain crucial in shaping investor perception and broader crypto market sentiment.

<Copyright ⓒ TokenPost, unauthorized reproduction and redistribution prohibited>

Bitcoin hovers near a pivotal $60,000 level as Arthur Hayes outlines two stark paths: a completed correction before renewed upside, or a deeper slide if equities unravel and liquidity tightens further. Arthur Hayes Maps 2 Bitcoin Paths: Sub-$60K Breakdown or Fed-Fueled Surge Past $126K Market volatility is reshaping bitcoin forecasts as macroeconomic risks evolve.

Coinbase’s Ethereum layer-2 network, Base, is transitioning away from relying solely on Optimism’s OP Stack as it seeks greater control over its technology and infrastructure. In a recent blog post titled “The Next Chapter for Base,” the team outlined plans to consolidate its development into a Base-managed codebase, marking a significant evolution for one of the fastest-growing Ethereum scaling solutions.

Base originally launched in 2023 using Optimism’s OP Stack, a popular toolkit designed to help developers build scalable layer-2 blockchains on Ethereum. Optimism itself is a layer-2 network that improves Ethereum’s performance by lowering transaction fees and speeding up settlement times. By leveraging this technology, Base quickly gained traction and now holds approximately $3.85 billion in total value locked (TVL), making it one of the leading Ethereum layer-2 networks in the market.

Under a prior agreement, Base could earn up to 118 million OP tokens over six years. However, following the announcement of this infrastructure shift, uncertainty remains about how the change may impact that arrangement. The OP token fell 4% in the 24 hours after the news broke, reflecting market reaction to the update.

Despite stepping back from direct reliance on the OP Stack, Base emphasized that it is not severing ties with Optimism. The network will continue collaborating with Optimism for support and maintain compatibility with OP Stack standards during the transition. For developers and everyday users, the changes are expected to be largely technical and not disruptive.

By managing its own technology stack, Base aims to accelerate innovation and streamline operations. The team plans to double its pace of major upgrades to around six per year, reinforcing its long-term commitment to scaling Ethereum and enhancing blockchain infrastructure.

<Copyright ⓒ TokenPost, unauthorized reproduction and redistribution prohibited>

Bitcoin (BTC) faced renewed selling pressure on Wednesday, sliding below the $66,000 level during U.S. afternoon trading and testing the lower boundary of its recent range. After briefly climbing to $68,500 overnight, the leading cryptocurrency reversed course and fell 2.5% over the past 24 hours, last trading near $66,200. The pullback puts bitcoin price action at a critical support zone that traders are watching closely.

The broader crypto market mirrored bitcoin’s decline, with major crypto stocks surrendering earlier gains. Coinbase (COIN), which had risen 3% earlier in the session, reversed into a 2% loss by the afternoon. MicroStrategy (MSTR), the largest corporate holder of bitcoin, also dropped about 3% as BTC weakened. The downturn highlights the strong correlation between bitcoin price movements and publicly traded crypto-related equities.

Traditional markets added to the pressure. U.S. stocks trimmed early advances after the release of the Federal Reserve’s January FOMC meeting minutes. While policymakers maintained their pause on rate cuts, several members suggested adopting “two-sided” guidance, signaling that further interest rate hikes remain possible if inflation persists. This more hawkish tone dampened risk appetite across financial markets.

At the same time, the U.S. dollar strengthened, with the Dollar Index (DXY) climbing to a two-week high. A stronger dollar typically weighs on risk assets such as cryptocurrencies, and Wednesday’s bitcoin sell-off aligned with that pattern.

If current losses hold, bitcoin is on track for its fifth consecutive weekly decline, marking its longest losing streak since the 2022 bear market. The $66,000 level now stands as a crucial support area after holding firm last week and fueling a rally above $70,000. A decisive break below this threshold could open the door to a retest of the $60,000 level or potentially deeper losses in the near term.

<Copyright ⓒ TokenPost, unauthorized reproduction and redistribution prohibited>

Intuit (INTU - Free Report) closed at $389.57 in the latest trading session, marking a +2.74% move from the prior day. The stock outpaced the S&P 500's daily gain of 0.56%. On the other hand, the Dow registered a gain of 0.26%, and the technology-centric Nasdaq increased by 0.78%.

Coming into today, shares of the maker of TurboTax, QuickBooks and other accounting software had lost 28.32% in the past month. In that same time, the Computer and Technology sector lost 4.09%, while the S&P 500 lost 1.27%.

Market participants will be closely following the financial results of Intuit in its upcoming release. The company plans to announce its earnings on February 26, 2026. The company's upcoming EPS is projected at $3.66, signifying a 10.24% increase compared to the same quarter of the previous year. Our most recent consensus estimate is calling for quarterly revenue of $4.53 billion, up 14.22% from the year-ago period.

For the full year, the Zacks Consensus Estimates are projecting earnings of $23.13 per share and revenue of $21.13 billion, which would represent changes of +14.79% and +12.21%, respectively, from the prior year.

Investors should also take note of any recent adjustments to analyst estimates for Intuit. These recent revisions tend to reflect the evolving nature of short-term business trends. Consequently, upward revisions in estimates express analysts' positivity towards the business operations and its ability to generate profits.

Research indicates that these estimate revisions are directly correlated with near-term share price momentum. Investors can capitalize on this by using the Zacks Rank. This model considers these estimate changes and provides a simple, actionable rating system.

The Zacks Rank system, ranging from #1 (Strong Buy) to #5 (Strong Sell), possesses a remarkable history of outdoing, externally audited, with #1 stocks returning an average annual gain of +25% since 1988. Over the past month, the Zacks Consensus EPS estimate has shifted 0.02% upward. Intuit presently features a Zacks Rank of #4 (Sell).

Looking at valuation, Intuit is presently trading at a Forward P/E ratio of 16.39. This signifies a premium in comparison to the average Forward P/E of 15.68 for its industry.

Meanwhile, INTU's PEG ratio is currently 1.15. This popular metric is similar to the widely-known P/E ratio, with the difference being that the PEG ratio also takes into account the company's expected earnings growth rate. The Computer - Software industry had an average PEG ratio of 1.35 as trading concluded yesterday.

The Computer - Software industry is part of the Computer and Technology sector. With its current Zacks Industry Rank of 74, this industry ranks in the top 31% of all industries, numbering over 250.

The Zacks Industry Rank evaluates the power of our distinct industry groups by determining the average Zacks Rank of the individual stocks forming the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.

Make sure to utilize Zacks.com to follow all of these stock-moving metrics, and more, in the coming trading sessions.

In the latest close session, Goldman Sachs (GS - Free Report) was up +1.93% at $933.73. This move outpaced the S&P 500's daily gain of 0.56%. On the other hand, the Dow registered a gain of 0.26%, and the technology-centric Nasdaq increased by 0.78%.

The stock of investment bank has fallen by 2.9% in the past month, lagging the Finance sector's loss of 1.23% and the S&P 500's loss of 1.27%.

The investment community will be paying close attention to the earnings performance of Goldman Sachs in its upcoming release. The company is expected to report EPS of $16.12, up 14.16% from the prior-year quarter. Our most recent consensus estimate is calling for quarterly revenue of $16.74 billion, up 11.16% from the year-ago period.

For the full year, the Zacks Consensus Estimates are projecting earnings of $56.62 per share and revenue of $63.29 billion, which would represent changes of +10.33% and +8.58%, respectively, from the prior year.

It is also important to note the recent changes to analyst estimates for Goldman Sachs. These revisions help to show the ever-changing nature of near-term business trends. Consequently, upward revisions in estimates express analysts' positivity towards the business operations and its ability to generate profits.

Our research demonstrates that these adjustments in estimates directly associate with imminent stock price performance. To take advantage of this, we've established the Zacks Rank, an exclusive model that considers these estimated changes and delivers an operational rating system.

The Zacks Rank system, which varies between #1 (Strong Buy) and #5 (Strong Sell), carries an impressive track record of exceeding expectations, confirmed by external audits, with stocks at #1 delivering an average annual return of +25% since 1988. Within the past 30 days, our consensus EPS projection has moved 0.41% higher. Goldman Sachs presently features a Zacks Rank of #2 (Buy).

In terms of valuation, Goldman Sachs is currently trading at a Forward P/E ratio of 16.18. Its industry sports an average Forward P/E of 14.35, so one might conclude that Goldman Sachs is trading at a premium comparatively.

We can also see that GS currently has a PEG ratio of 1.12. The PEG ratio bears resemblance to the frequently used P/E ratio, but this parameter also includes the company's expected earnings growth trajectory. The Financial - Investment Bank industry currently had an average PEG ratio of 1.15 as of yesterday's close.

The Financial - Investment Bank industry is part of the Finance sector. At present, this industry carries a Zacks Industry Rank of 35, placing it within the top 15% of over 250 industries.

The strength of our individual industry groups is measured by the Zacks Industry Rank, which is calculated based on the average Zacks Rank of the individual stocks within these groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.

You can find more information on all of these metrics, and much more, on Zacks.com.

In the latest close session, DXP Enterprises (DXPE - Free Report) was down 1.04% at $147.44. This change lagged the S&P 500's daily gain of 0.56%. Elsewhere, the Dow gained 0.26%, while the tech-heavy Nasdaq added 0.78%.

Shares of the industrial products supplier witnessed a gain of 20.56% over the previous month, beating the performance of the Industrial Products sector with its gain of 9.04%, and the S&P 500's loss of 1.27%.

The upcoming earnings release of DXP Enterprises will be of great interest to investors. The company is predicted to post an EPS of $0.91, indicating a 34.06% decline compared to the equivalent quarter last year. Meanwhile, the latest consensus estimate predicts the revenue to be $498.31 million, indicating a 5.82% increase compared to the same quarter of the previous year.

For the full year, the Zacks Consensus Estimates project earnings of $5.03 per share and a revenue of $1.99 billion, demonstrating changes of +11.53% and +10.28%, respectively, from the preceding year.

Any recent changes to analyst estimates for DXP Enterprises should also be noted by investors. These latest adjustments often mirror the shifting dynamics of short-term business patterns. Consequently, upward revisions in estimates express analysts' positivity towards the business operations and its ability to generate profits.

Empirical research indicates that these revisions in estimates have a direct correlation with impending stock price performance. To capitalize on this, we've crafted the Zacks Rank, a unique model that incorporates these estimate changes and offers a practical rating system.

The Zacks Rank system ranges from #1 (Strong Buy) to #5 (Strong Sell). It has a remarkable, outside-audited track record of success, with #1 stocks delivering an average annual return of +25% since 1988. Over the past month, there's been no change in the Zacks Consensus EPS estimate. Currently, DXP Enterprises is carrying a Zacks Rank of #3 (Hold).

With respect to valuation, DXP Enterprises is currently being traded at a Forward P/E ratio of 28.16. This signifies a premium in comparison to the average Forward P/E of 26.43 for its industry.

The Manufacturing - General Industrial industry is part of the Industrial Products sector. At present, this industry carries a Zacks Industry Rank of 65, placing it within the top 27% of over 250 industries.

The Zacks Industry Rank assesses the strength of our separate industry groups by calculating the average Zacks Rank of the individual stocks contained within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.

Be sure to use Zacks.com to monitor all these stock-influencing metrics, and more, throughout the forthcoming trading sessions.

In the latest trading session, Zoom Communications (ZM - Free Report) closed at $91.12, marking a +2.79% move from the previous day. The stock exceeded the S&P 500, which registered a gain of 0.56% for the day. Elsewhere, the Dow gained 0.26%, while the tech-heavy Nasdaq added 0.78%.

The video-conferencing company's shares have seen an increase of 9.01% over the last month, surpassing the Computer and Technology sector's loss of 4.09% and the S&P 500's loss of 1.27%.

The investment community will be paying close attention to the earnings performance of Zoom Communications in its upcoming release. The company is slated to reveal its earnings on February 25, 2026. On that day, Zoom Communications is projected to report earnings of $1.48 per share, which would represent year-over-year growth of 4.96%. At the same time, our most recent consensus estimate is projecting a revenue of $1.23 billion, reflecting a 4.08% rise from the equivalent quarter last year.

Looking at the full year, the Zacks Consensus Estimates suggest analysts are expecting earnings of $5.96 per share and revenue of $4.85 billion. These totals would mark changes of +7.58% and +4%, respectively, from last year.

Investors should also note any recent changes to analyst estimates for Zoom Communications. Such recent modifications usually signify the changing landscape of near-term business trends. Consequently, upward revisions in estimates express analysts' positivity towards the business operations and its ability to generate profits.

Our research suggests that these changes in estimates have a direct relationship with upcoming stock price performance. To capitalize on this, we've crafted the Zacks Rank, a unique model that incorporates these estimate changes and offers a practical rating system.

The Zacks Rank system, running from #1 (Strong Buy) to #5 (Strong Sell), holds an admirable track record of superior performance, independently audited, with #1 stocks contributing an average annual return of +25% since 1988. Over the last 30 days, the Zacks Consensus EPS estimate has witnessed an unchanged state. As of now, Zoom Communications holds a Zacks Rank of #3 (Hold).

In terms of valuation, Zoom Communications is currently trading at a Forward P/E ratio of 14.93. Its industry sports an average Forward P/E of 19.47, so one might conclude that Zoom Communications is trading at a discount comparatively.

Meanwhile, ZM's PEG ratio is currently 5.2. This popular metric is similar to the widely-known P/E ratio, with the difference being that the PEG ratio also takes into account the company's expected earnings growth rate. ZM's industry had an average PEG ratio of 1.1 as of yesterday's close.

The Internet - Software industry is part of the Computer and Technology sector. Currently, this industry holds a Zacks Industry Rank of 128, positioning it in the bottom 48% of all 250+ industries.

The Zacks Industry Rank is ordered from best to worst in terms of the average Zacks Rank of the individual companies within each of these sectors. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.

Be sure to use Zacks.com to monitor all these stock-influencing metrics, and more, throughout the forthcoming trading sessions.

Community Health Systems (CYH - Free Report) reported break-even quarterly earnings per share versus the Zacks Consensus Estimate of a loss of $0.32. This compares to a loss of $0.42 per share a year ago. These figures are adjusted for non-recurring items.

This quarterly report represents an earnings surprise of +100.00%. A quarter ago, it was expected that this operator of accute care hospitals would post a loss of $0.32 per share when it actually produced earnings of $1.27, delivering a surprise of +496.88%.

Over the last four quarters, the company has surpassed consensus EPS estimates three times.

Community Health Systems, which belongs to the Zacks Medical - Hospital industry, posted revenues of $3.11 billion for the quarter ended December 2025, missing the Zacks Consensus Estimate by 1.18%. This compares to year-ago revenues of $3.27 billion. The company has topped consensus revenue estimates three times over the last four quarters.

The sustainability of the stock's immediate price movement based on the recently-released numbers and future earnings expectations will mostly depend on management's commentary on the earnings call.

Community Health Systems shares have added about 10.3% since the beginning of the year versus the S&P 500's zero return.

What's Next for Community Health Systems?While Community Health Systems has outperformed the market so far this year, the question that comes to investors' minds is: what's next for the stock?

There are no easy answers to this key question, but one reliable measure that can help investors address this is the company's earnings outlook. Not only does this include current consensus earnings expectations for the coming quarter(s), but also how these expectations have changed lately.

Empirical research shows a strong correlation between near-term stock movements and trends in earnings estimate revisions. Investors can track such revisions by themselves or rely on a tried-and-tested rating tool like the Zacks Rank, which has an impressive track record of harnessing the power of earnings estimate revisions.

Ahead of this earnings release, the estimate revisions trend for Community Health Systems was mixed. While the magnitude and direction of estimate revisions could change following the company's just-released earnings report, the current status translates into a Zacks Rank #3 (Hold) for the stock. So, the shares are expected to perform in line with the market in the near future. You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here.

It will be interesting to see how estimates for the coming quarters and the current fiscal year change in the days ahead. The current consensus EPS estimate is -$0.19 on $3.16 billion in revenues for the coming quarter and -$0.51 on $12.73 billion in revenues for the current fiscal year.

Investors should be mindful of the fact that the outlook for the industry can have a material impact on the performance of the stock as well. In terms of the Zacks Industry Rank, Medical - Hospital is currently in the bottom 28% of the 250 plus Zacks industries. Our research shows that the top 50% of the Zacks-ranked industries outperform the bottom 50% by a factor of more than 2 to 1.

Universal Health Services (UHS - Free Report) , another stock in the same industry, has yet to report results for the quarter ended December 2025. The results are expected to be released on February 25.

This hospital and health facility operator is expected to post quarterly earnings of $5.91 per share in its upcoming report, which represents a year-over-year change of +20.1%. The consensus EPS estimate for the quarter has remained unchanged over the last 30 days.

Universal Health Services' revenues are expected to be $4.48 billion, up 9% from the year-ago quarter.

, /PRNewswire/ --

Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Ramaco Resources, Inc. (NASDAQ: METC) between July 31, 2025 and October 23, 2025, both dates inclusive (the "Class Period"), of the important March 31, 2026 lead plaintiff deadline.

So What: If you purchased Ramaco securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

What to do Next: To join the Ramaco class action, go to https://rosenlegal.com/submit-form/?case_id=52081 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than March 31, 2026. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.

Why Rosen Law: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources, or any meaningful peer recognition. Many of these firms do not actually litigate securities class actions, but are merely middlemen that refer clients or partner with law firms that actually litigate the cases. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm has achieved, at that time, the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs' Bar. Many of the firm's attorneys have been recognized by Lawdragon and Super Lawyers.

Details of the Case: According to the lawsuit, throughout the Class Period, defendants made materially false and/or misleading statements and/or failed to disclose that: (1) defendants had not commenced any significant mining activity at the Brook Mine after groundbreaking; (2) no active work was taking place at the Brook Mine; (3) as a result, Ramaco overstated development progress at the Brook Mine; and (4) as a result of the foregoing, defendants' positive statements about Ramaco's business, operations, and prospects were materially misleading and/or lacked a reasonable basis. When the true details entered the market, the lawsuit claims that investors suffered damages.

To join the Ramaco class action, go to https://rosenlegal.com/submit-form/?case_id=52081 https://rosenlegal.com/submit-form/?case_id=50622 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action.

No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor's ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.

Attorney Advertising. Prior results do not guarantee a similar outcome.

Contact Information:

      Laurence Rosen, Esq.
      Phillip Kim, Esq.
      The Rosen Law Firm, P.A.
      275 Madison Avenue, 40th Floor
      New York, NY 10016
      Tel: (212) 686-1060
      Toll Free: (866) 767-3653
      Fax: (212) 202-3827
      [email protected]
      www.rosenlegal.com

SOURCE THE ROSEN LAW FIRM, P. A.

Tutor Perini (TPC - Free Report) closed at $81.10 in the latest trading session, marking a -1.39% move from the prior day. The stock fell short of the S&P 500, which registered a gain of 0.56% for the day. At the same time, the Dow added 0.26%, and the tech-heavy Nasdaq gained 0.78%.

Shares of the construction company witnessed a gain of 10.94% over the previous month, beating the performance of the Construction sector with its gain of 6.35%, and the S&P 500's loss of 1.27%.

Investors will be eagerly watching for the performance of Tutor Perini in its upcoming earnings disclosure. The company's earnings per share (EPS) are projected to be $0.92, reflecting a 160.93% increase from the same quarter last year. Meanwhile, the Zacks Consensus Estimate for revenue is projecting net sales of $1.28 billion, up 19.85% from the year-ago period.

In terms of the entire fiscal year, the Zacks Consensus Estimates predict earnings of $4.01 per share and a revenue of $5.32 billion, indicating changes of +228.12% and +22.84%, respectively, from the former year.

Investors should also pay attention to any latest changes in analyst estimates for Tutor Perini. These recent revisions tend to reflect the evolving nature of short-term business trends. Consequently, upward revisions in estimates express analysts' positivity towards the business operations and its ability to generate profits.

Research indicates that these estimate revisions are directly correlated with near-term share price momentum. To take advantage of this, we've established the Zacks Rank, an exclusive model that considers these estimated changes and delivers an operational rating system.

The Zacks Rank system, running from #1 (Strong Buy) to #5 (Strong Sell), holds an admirable track record of superior performance, independently audited, with #1 stocks contributing an average annual return of +25% since 1988. Within the past 30 days, our consensus EPS projection remained stagnant. Right now, Tutor Perini possesses a Zacks Rank of #3 (Hold).

In the context of valuation, Tutor Perini is at present trading with a Forward P/E ratio of 17.42. This indicates a discount in contrast to its industry's Forward P/E of 27.62.

The Building Products - Heavy Construction industry is part of the Construction sector. At present, this industry carries a Zacks Industry Rank of 149, placing it within the bottom 40% of over 250 industries.

The Zacks Industry Rank evaluates the power of our distinct industry groups by determining the average Zacks Rank of the individual stocks forming the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.

Ensure to harness Zacks.com to stay updated with all these stock-shifting metrics, among others, in the next trading sessions.

Recursion Pharmaceuticals (RXRX - Free Report) ended the recent trading session at $3.53, demonstrating a +2.02% change from the preceding day's closing price. This move outpaced the S&P 500's daily gain of 0.56%. Elsewhere, the Dow gained 0.26%, while the tech-heavy Nasdaq added 0.78%.

Shares of the biotechnology company witnessed a loss of 21.36% over the previous month, trailing the performance of the Medical sector with its gain of 0.65%, and the S&P 500's loss of 1.27%.

Market participants will be closely following the financial results of Recursion Pharmaceuticals in its upcoming release. The company is expected to report EPS of -$0.28, up 47.17% from the prior-year quarter. Meanwhile, the Zacks Consensus Estimate for revenue is projecting net sales of $25.5 million, up 460.44% from the year-ago period.

Regarding the entire year, the Zacks Consensus Estimates forecast earnings of -$1.59 per share and revenue of $64.62 million, indicating changes of +5.92% and +9.83%, respectively, compared to the previous year.

Additionally, investors should keep an eye on any recent revisions to analyst forecasts for Recursion Pharmaceuticals. These latest adjustments often mirror the shifting dynamics of short-term business patterns. Consequently, upward revisions in estimates express analysts' positivity towards the business operations and its ability to generate profits.

Our research demonstrates that these adjustments in estimates directly associate with imminent stock price performance. Investors can capitalize on this by using the Zacks Rank. This model considers these estimate changes and provides a simple, actionable rating system.

Ranging from #1 (Strong Buy) to #5 (Strong Sell), the Zacks Rank system has a proven, outside-audited track record of outperformance, with #1 stocks returning an average of +25% annually since 1988. Over the past month, the Zacks Consensus EPS estimate has remained steady. At present, Recursion Pharmaceuticals boasts a Zacks Rank of #2 (Buy).

The Medical - Biomedical and Genetics industry is part of the Medical sector. At present, this industry carries a Zacks Industry Rank of 87, placing it within the top 36% of over 250 industries.

The Zacks Industry Rank gauges the strength of our industry groups by measuring the average Zacks Rank of the individual stocks within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.

Ensure to harness Zacks.com to stay updated with all these stock-shifting metrics, among others, in the next trading sessions.

In the latest close session, On Holding (ONON - Free Report) was up +1.44% at $47.33. The stock outpaced the S&P 500's daily gain of 0.56%. Meanwhile, the Dow experienced a rise of 0.26%, and the technology-dominated Nasdaq saw an increase of 0.78%.

Shares of the running-shoe and apparel company have appreciated by 5.76% over the course of the past month, outperforming the Retail-Wholesale sector's loss of 5.72%, and the S&P 500's loss of 1.27%.

The investment community will be paying close attention to the earnings performance of On Holding in its upcoming release. The company is slated to reveal its earnings on March 3, 2026. The company's upcoming EPS is projected at $0.26, signifying a 31.58% drop compared to the same quarter of the previous year. Meanwhile, the Zacks Consensus Estimate for revenue is projecting net sales of $896.42 million, up 29.68% from the year-ago period.

Looking at the full year, the Zacks Consensus Estimates suggest analysts are expecting earnings of $0.94 per share and revenue of $3.73 billion. These totals would mark changes of -14.55% and +41.37%, respectively, from last year.

Additionally, investors should keep an eye on any recent revisions to analyst forecasts for On Holding. These revisions typically reflect the latest short-term business trends, which can change frequently. With this in mind, we can consider positive estimate revisions a sign of optimism about the business outlook.

Empirical research indicates that these revisions in estimates have a direct correlation with impending stock price performance. To capitalize on this, we've crafted the Zacks Rank, a unique model that incorporates these estimate changes and offers a practical rating system.

Ranging from #1 (Strong Buy) to #5 (Strong Sell), the Zacks Rank system has a proven, outside-audited track record of outperformance, with #1 stocks returning an average of +25% annually since 1988. The Zacks Consensus EPS estimate has moved 0.02% higher within the past month. Currently, On Holding is carrying a Zacks Rank of #1 (Strong Buy).

With respect to valuation, On Holding is currently being traded at a Forward P/E ratio of 27.22. This denotes a premium relative to the industry average Forward P/E of 17.25.

It's also important to note that ONON currently trades at a PEG ratio of 1.16. The PEG ratio is akin to the commonly utilized P/E ratio, but this measure also incorporates the company's anticipated earnings growth rate. As of the close of trade yesterday, the Retail - Apparel and Shoes industry held an average PEG ratio of 1.89.

The Retail - Apparel and Shoes industry is part of the Retail-Wholesale sector. This industry currently has a Zacks Industry Rank of 41, which puts it in the top 17% of all 250+ industries.

The Zacks Industry Rank gauges the strength of our individual industry groups by measuring the average Zacks Rank of the individual stocks within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.

Make sure to utilize Zacks.com to follow all of these stock-moving metrics, and more, in the coming trading sessions.

Norwegian Cruise Line (NCLH - Free Report) closed the most recent trading day at $24.35, moving +1.04% from the previous trading session. The stock's change was more than the S&P 500's daily gain of 0.56%. Elsewhere, the Dow gained 0.26%, while the tech-heavy Nasdaq added 0.78%.

Shares of the cruise operator have appreciated by 18.31% over the course of the past month, outperforming the Consumer Discretionary sector's loss of 2.26%, and the S&P 500's loss of 1.27%.

The investment community will be closely monitoring the performance of Norwegian Cruise Line in its forthcoming earnings report. The company is scheduled to release its earnings on March 2, 2026. The company is expected to report EPS of $0.28, up 7.69% from the prior-year quarter. Our most recent consensus estimate is calling for quarterly revenue of $2.35 billion, up 11.49% from the year-ago period.

For the full year, the Zacks Consensus Estimates are projecting earnings of $2.12 per share and revenue of $9.94 billion, which would represent changes of +16.48% and +4.87%, respectively, from the prior year.

It's also important for investors to be aware of any recent modifications to analyst estimates for Norwegian Cruise Line. These revisions help to show the ever-changing nature of near-term business trends. As a result, we can interpret positive estimate revisions as a good sign for the business outlook.

Our research demonstrates that these adjustments in estimates directly associate with imminent stock price performance. To capitalize on this, we've crafted the Zacks Rank, a unique model that incorporates these estimate changes and offers a practical rating system.

The Zacks Rank system ranges from #1 (Strong Buy) to #5 (Strong Sell). It has a remarkable, outside-audited track record of success, with #1 stocks delivering an average annual return of +25% since 1988. Over the last 30 days, the Zacks Consensus EPS estimate has witnessed a 3.76% decrease. Norwegian Cruise Line currently has a Zacks Rank of #3 (Hold).

From a valuation perspective, Norwegian Cruise Line is currently exchanging hands at a Forward P/E ratio of 9.41. This valuation marks a discount compared to its industry average Forward P/E of 19.1.

Meanwhile, NCLH's PEG ratio is currently 0.55. The PEG ratio is similar to the widely-used P/E ratio, but this metric also takes the company's expected earnings growth rate into account. Leisure and Recreation Services stocks are, on average, holding a PEG ratio of 1.43 based on yesterday's closing prices.

The Leisure and Recreation Services industry is part of the Consumer Discretionary sector. This group has a Zacks Industry Rank of 194, putting it in the bottom 21% of all 250+ industries.

The strength of our individual industry groups is measured by the Zacks Industry Rank, which is calculated based on the average Zacks Rank of the individual stocks within these groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.

Ensure to harness Zacks.com to stay updated with all these stock-shifting metrics, among others, in the next trading sessions.

Armour Residential REIT (ARR - Free Report) came out with quarterly earnings of $0.71 per share, missing the Zacks Consensus Estimate of $0.74 per share. This compares to earnings of $0.78 per share a year ago. These figures are adjusted for non-recurring items.

This quarterly report represents an earnings surprise of -4.05%. A quarter ago, it was expected that this real estate investment trust would post earnings of $0.75 per share when it actually produced earnings of $0.72, delivering a surprise of -4%.

Over the last four quarters, the company has not been able to surpass consensus EPS estimates.

Armour Residential REIT, which belongs to the Zacks REIT and Equity Trust industry, posted revenues of $50.38 million for the quarter ended December 2025, surpassing the Zacks Consensus Estimate by 18.25%. This compares to year-ago revenues of $12.66 million. The company has topped consensus revenue estimates two times over the last four quarters.

The sustainability of the stock's immediate price movement based on the recently-released numbers and future earnings expectations will mostly depend on management's commentary on the earnings call.

Armour Residential REIT shares have added about 0.5% since the beginning of the year versus the S&P 500's zero return.

What's Next for Armour Residential REIT?While Armour Residential REIT has outperformed the market so far this year, the question that comes to investors' minds is: what's next for the stock?

There are no easy answers to this key question, but one reliable measure that can help investors address this is the company's earnings outlook. Not only does this include current consensus earnings expectations for the coming quarter(s), but also how these expectations have changed lately.

Empirical research shows a strong correlation between near-term stock movements and trends in earnings estimate revisions. Investors can track such revisions by themselves or rely on a tried-and-tested rating tool like the Zacks Rank, which has an impressive track record of harnessing the power of earnings estimate revisions.

Ahead of this earnings release, the estimate revisions trend for Armour Residential REIT was mixed. While the magnitude and direction of estimate revisions could change following the company's just-released earnings report, the current status translates into a Zacks Rank #3 (Hold) for the stock. So, the shares are expected to perform in line with the market in the near future. You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here.

It will be interesting to see how estimates for the coming quarters and the current fiscal year change in the days ahead. The current consensus EPS estimate is $0.73 on $72.4 million in revenues for the coming quarter and $3.02 on $307.7 million in revenues for the current fiscal year.

Investors should be mindful of the fact that the outlook for the industry can have a material impact on the performance of the stock as well. In terms of the Zacks Industry Rank, REIT and Equity Trust is currently in the bottom 24% of the 250 plus Zacks industries. Our research shows that the top 50% of the Zacks-ranked industries outperform the bottom 50% by a factor of more than 2 to 1.

One other stock from the same industry, Arbor Realty Trust (ABR - Free Report) , is yet to report results for the quarter ended December 2025. The results are expected to be released on February 27.

This real estate investment trust is expected to post quarterly earnings of $0.21 per share in its upcoming report, which represents a year-over-year change of -47.5%. The consensus EPS estimate for the quarter has remained unchanged over the last 30 days.

Arbor Realty Trust's revenues are expected to be $221.71 million, down 15.7% from the year-ago quarter.

ONE Gas (OGS - Free Report) came out with quarterly earnings of $1.48 per share, beating the Zacks Consensus Estimate of $1.42 per share. This compares to earnings of $1.34 per share a year ago. These figures are adjusted for non-recurring items.

This quarterly report represents an earnings surprise of +4.04%. A quarter ago, it was expected that this natural gas distribution would post earnings of $0.44 per share when it actually produced earnings of $0.44, delivering no surprise.

Over the last four quarters, the company has surpassed consensus EPS estimates two times.

ONE Gas, which belongs to the Zacks Utility - Gas Distribution industry, posted revenues of $689.37 million for the quarter ended December 2025, surpassing the Zacks Consensus Estimate by 2.10%. This compares to year-ago revenues of $630.7 million. The company has topped consensus revenue estimates three times over the last four quarters.

The sustainability of the stock's immediate price movement based on the recently-released numbers and future earnings expectations will mostly depend on management's commentary on the earnings call.

ONE Gas shares have added about 11% since the beginning of the year versus the S&P 500's zero return.

What's Next for ONE Gas?While ONE Gas has outperformed the market so far this year, the question that comes to investors' minds is: what's next for the stock?

There are no easy answers to this key question, but one reliable measure that can help investors address this is the company's earnings outlook. Not only does this include current consensus earnings expectations for the coming quarter(s), but also how these expectations have changed lately.

Empirical research shows a strong correlation between near-term stock movements and trends in earnings estimate revisions. Investors can track such revisions by themselves or rely on a tried-and-tested rating tool like the Zacks Rank, which has an impressive track record of harnessing the power of earnings estimate revisions.

Ahead of this earnings release, the estimate revisions trend for ONE Gas was mixed. While the magnitude and direction of estimate revisions could change following the company's just-released earnings report, the current status translates into a Zacks Rank #3 (Hold) for the stock. So, the shares are expected to perform in line with the market in the near future. You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here.

It will be interesting to see how estimates for the coming quarters and the current fiscal year change in the days ahead. The current consensus EPS estimate is $2.14 on $957.86 million in revenues for the coming quarter and $4.71 on $2.54 billion in revenues for the current fiscal year.

Investors should be mindful of the fact that the outlook for the industry can have a material impact on the performance of the stock as well. In terms of the Zacks Industry Rank, Utility - Gas Distribution is currently in the bottom 45% of the 250 plus Zacks industries. Our research shows that the top 50% of the Zacks-ranked industries outperform the bottom 50% by a factor of more than 2 to 1.

Another stock from the same industry, Clean Energy Fuels (CLNE - Free Report) , has yet to report results for the quarter ended December 2025. The results are expected to be released on February 24.

This provider of natural gas as an alternative fuel for vehicle fleets is expected to post quarterly loss of $0.03 per share in its upcoming report, which represents a year-over-year change of -250%. The consensus EPS estimate for the quarter has remained unchanged over the last 30 days.

Clean Energy Fuels' revenues are expected to be $92.38 million, down 15.5% from the year-ago quarter.

PHILADELPHIA and VANCOUVER, British Columbia, Feb. 18, 2026 (GLOBE NEWSWIRE) -- BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXW, BCTXZ, BCTXL) (TSX: BCT) (“BriaCell”), a clinical-stage biotechnology company that develops novel immunotherapies to transform cancer care, and its majority-owned subsidiary, BriaPro Therapeutics Corp. (“BriaPro”), are pleased to announce that they have entered into a definitive purchase agreement (the “Purchase Agreement”) pursuant to which BriaPro has agreed to purchase BriaCell’s exclusive license to develop and commercialize Soluble CD80 (“sCD80”) as a biologic agent for the treatment of cancer and other associated assets (the “Transaction”).

Background

BriaCell originally secured the exclusive license from the University of Maryland, Baltimore County (“UMBC”) on August 2, 2022. The novel technology, originally developed by Suzanne Ostrand-Rosenberg, Ph.D., Emeritus Faculty at UMBC, and member of BriaCell’s scientific advisory board, is titled “Soluble CD80 as a Therapeutic to Reverse Immune Suppression in Cancer Patients” and is covered under USPN 8,956,619 B2, USPN 9,650,429 B2, and USPN 10,377,810 B2. In animal models, sCD80 was well-tolerated and stopped tumor growth by potentially restoring natural anti-tumor immunity (see Lucas A Horn, et al. and Samuel T Haile et al. in collaboration with Dr. Ostrand-Rosenberg). Additionally, strong anti-tumor activity of sCD80 has been reported in multiple tumor types (see Lucas A Horn, et al.). Importantly, as demonstrated in the same studies, sCD80’s unique actions may involve both awakening and boosting the immune system to recognize and destroy tumor cells.

The Transaction

Under the terms of the Purchase Agreement, BriaPro gains the worldwide rights to develop and commercialize sCD80 as a therapeutic agent for the treatment of cancer, while UMBC holds all rights, title and interest in the inventions and the patent, except for certain rights retained by the United States Government. BriaPro will pay 2% royalties to UMBC upon the commercialization of the product plus other development costs.

As part of the Transaction, BriaCell will make available to BriaPro up to $3 million to fund research and development efforts (the “Credit Facility”). Each drawdown under the Credit Facility will be subject to BriaCell’s approval regarding the use of funds.

As consideration for the transfer of the exclusive license and the Credit Facility, BriaPro will issue to BriaCell 23,972,589 Common Shares at an aggregate value of approximately C$1.18M, increasing BriaCell’s interest in BriaPro to approximately 78% post-transaction. The Transaction is expected to close on or around March 12, 2026, subject to certain conditions including (i) approval of the disinterested shareholders of BriaPro, and (ii) receipt of a third-party valuation confirming that the Transaction is occurring at fair market value.

Shareholder Approval

In accordance with Multilateral Instrument 61-101 – Protection of Minority Security Holders in Special Transactions (“MI 61-101”), the resolution approving the Purchase Agreement must be approved by a simple majority of votes cast by shareholders, present in person or represented by proxy and entitled to vote at the Meeting, excluding the votes cast by any “interested party” (as defined in MI 61-101). As a 10% shareholder with an interest in the Transaction, BriaCell's shareholdings in BriaPro will be excluded from voting.

Formal Valuation Requirements

In respect of the formal valuation requirement of MI 61-101, BriaPro intends to rely on the specified markets exemptions set forth in subsection 5.5(b) of MI 61-101, as none of its securities are listed or quoted on a specified senior exchange.

Though a formal valuation is not required under applicable securities laws, as a matter of good governance and best corporate practice, BriaPro intends to obtain a valuation from an independent third-party valuator as a condition to closing, verifying and validating that Transaction is occurring at fair market value.

“Our mission has been to develop safe and effective treatments for cancer patients who do not respond to existing treatments, and a transformational anti-cancer agent such as sCD80 may provide us with such an additional opportunity,” stated Dr. Bill Williams, BriaCell and BriaPro's President and CEO. “Based on the promising data in animal studies, we plan to explore the potential use of sCD80 technology as a therapeutic agent in combination with our other immunotherapies or on its own. We look forward to accelerating the development of this novel anti-cancer agent to bring hope to patients who need it the most.”

About BriaCell Therapeutics Corp.

BriaCell is a clinical-stage biotechnology company that develops novel immunotherapies to transform cancer care. More information is available at https://briacell.com/.

About BriaPro Therapeutics Corp.

BriaPro is a pre-clinical stage immunotherapy company developing binding agents and proteins with the intention to boost the ability of the body’s own cancer-fighting cells to destroy cancerous tumors.

Safe Harbor

This press release contains “forward-looking statements” that are subject to substantial risks and uncertainties. All statements, other than statements of historical fact, contained in this press release are forward-looking statements. Forward-looking statements contained in this press release may be identified by the use of words such as “anticipate,” “believe,” “contemplate,” “could,” “estimate,” “expect,” “intend,” “seek,” “may,” “might,” “plan,” “potential,” “predict,” “project,” “target,” “aim,” “should,” “will,” “would,” or the negative of these words or other similar expressions, although not all forward-looking statements contain these words. Examples of forward-looking statements in this news release include, among others, statements that BriaCell and BriaPro make regarding the potential for development and commercialization of sCD80 as a biologic agent for the treatment of cancer, and the possibility that sCD80 may awaken and boost the immune system to recognize and destroy tumor cells. Forward-looking statements are based on BriaCell and BriaPro’s current expectations and are subject to inherent uncertainties, risks and assumptions that are difficult to predict. Further, certain forward-looking statements are based on assumptions as to future events that may not prove to be accurate. These and other risks and uncertainties are described more fully under the heading “Risks and Uncertainties” in BriaCell and BriaPro’s most recent Management’s Discussion and Analysis, under the heading “Risk Factors” in BriaCell’s most recent Annual Information Form, and under “Risks and Uncertainties” in: (i) BriaCell’s other filings with the Canadian securities regulatory authorities and the U.S. Securities and Exchange Commission, and (ii) BriaPro’s other filings with the Canadian securities regulatory authorities, all of which are available under BriaCell and BriaPro’s profiles on SEDAR+ at www.sedarplus.ca and on BriaCell’s profile on EDGAR at www.sec.gov. Forward-looking statements contained in this announcement are made as of this date. BriaCell Therapeutics Corp. and BriaPro Therapeutics Corp. undertake no duty to update such information except as required under applicable law.

Neither the Toronto Stock Exchange nor its Regulation Services Provider (as that term is defined in the policies of the Toronto Stock Exchange) accepts responsibility for the adequacy or accuracy of this release.

Contact Information

BriaCell and BriaPro Contact:
William V. Williams, MD
President & CEO, BriaCell and BriaPro
1-888-485-6340
[email protected]

Investor Relations Contact:
[email protected]

NEW YORK, Feb. 18, 2026 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE).

Shareholders who purchased shares of RARE during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery.

CONTACT US HERE:

https://securitiesclasslaw.com/securities/ultragenyx-pharmaceutical-inc-loss-submission-form-2/?id=183592&from=3 

CLASS PERIOD: August 3, 2023 to December 26, 2025

ALLEGATIONS: According to the complaint, defendants provided overwhelmingly positive statements to investors while, at the same time, disseminating materially false and misleading statements and/or concealing material adverse facts concerning the true state of setrusumab’s potential and the true risk inherent in the study protocols put forth; notably, that, while setrusumab does increase material bone density, this increase does not correlate to a decrease in annualized fracture rates or otherwise the Phase III Orbit and Cosmic studies were much less likely to be able to demonstrate such a link than management claimed. On December 29, 2025, Ultragenyx announced that both its Phase III Orbit and Cosmic Studies had not “achieved statistical significance against the primary endpoints of reduction in annualized clinical fracture rate compared to placebo or bisphosphonates, respectively.” The Company attributed the study failure to a “low fracture rate in the placebo group” of Orbit and a trend that fell shy of statistical significance in Cosmic. Following this news, the price of Ultragenyx’s common stock declined dramatically. From a closing market price of $34.19 per share on December 26, 2025, Ultragenyx’s stock price fell to $19.72 per share on December 29, 2025, a decline of about 42.32% in the span of just a single day.

DEADLINE: April 6, 2026 Shareholders should not delay in registering for this class action. Register your information here: https://securitiesclasslaw.com/securities/ultragenyx-pharmaceutical-inc-loss-submission-form-2/?id=183592&from=3 

NEXT STEPS FOR SHAREHOLDERS: Once you register as a shareholder who purchased shares of RARE during the timeframe listed above, you will be enrolled in a portfolio monitoring software to provide you with status updates throughout the lifecycle of the case. The deadline to seek to be a lead plaintiff is April 6, 2026. There is no cost or obligation to you to participate in this case.

WHY GROSS LAW FIRM? The Gross Law Firm is a nationally recognized class action law firm, and our mission is to protect the rights of all investors who have suffered as a result of deceit, fraud, and illegal business practices. The Gross Law Firm is committed to ensuring that companies adhere to responsible business practices and engage in good corporate citizenship. The firm seeks recovery on behalf of investors who incurred losses when false and/or misleading statements or the omission of material information by a company lead to artificial inflation of the company's stock. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:
The Gross Law Firm
15 West 38th Street, 12th floor
New York, NY, 10018
Email: [email protected] 
Phone: (646) 453-8903

Analyst’s Disclosure: I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.